Cidara Therapeutics Inc. (NASDAQ: CDTX) Stock Information | RedChip

Cidara Therapeutics Inc. (NASDAQ: CDTX)


$23.5900
+0.3700 ( +3.01% ) 26.4K

Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.

Market Data


Open


$23.5900

Previous close


$23.2200

Volume


26.4K

Market cap


$245.58M

Day range


$22.0490 - $23.5690

52 week range


$10.0040 - $24.9900

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Apr 30, 2024
3 Insider transactions 1 Apr 30, 2024
3 Insider transactions 1 Apr 30, 2024
3 Insider transactions 1 Apr 30, 2024
4 Insider transactions 1 Apr 30, 2024
4 Insider transactions 1 Apr 30, 2024
4 Insider transactions 1 Apr 30, 2024
3 Insider transactions 1 Apr 30, 2024
8-k/a 8K-related 16 Apr 29, 2024
8-k 8K-related 13 Apr 24, 2024

Latest News